Karen Sterling

Stock Analyst

(n/a)
# 0
Out of 0 analysts
1
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by Karen Sterling

enGene Therapeutics
Apr 13, 2026
Initiates: Buy
Price Target: $22
Current: $7.60
Upside: +182.89%